Clinical Trial Update: Clinical Evaluation Of The SonR Atrial Lead In Paradym RF Device [Phase 3]

View source ↗

Summary

Phase 3 clinical evaluation of the SonR Atrial Lead in the Paradym RF device has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Paradym RF Device
• SonR Atrial Lead

Snippet

Sponsor: LivaNova | Conditions: Heart Failure | Phase 3 | Status: COMPLETED